EFPIA Response To The A (H1N1) Novel Influenza Virus

EFPIA is aware and concerned by the current outbreak of a novel influenza, which appears to have originated in Mexico. We note the WHO’s decision to raise the level of influenza pandemic alert from the current phase 4 to phase 5. We will continue to monitor the situation closely, working with our colleagues at the International Federation of Pharmaceutical manufacturers and Associations.

More: continued here

Filed under: Bird Flu on May 6th, 2009